Isobutane

Isobutane

SCHEMBL3111122

CC(C)C.[AlH3].[LiH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isobutane SCHEMBL27701505 0.91
Isobutane SCHEMBL1443407 0.91
Isobutane SCHEMBL2142427 0.83
Isobutane SCHEMBL27629842 0.83
Isobutane SCHEMBL5886653 0.83
Isobutane SCHEMBL14958385 0.83 ALDH1A1 (0.38)
Isobutane SCHEMBL27610905 0.83
Isobutane SCHEMBL28805777 0.83
Isobutane SCHEMBL7754023 0.82 TSHR (0.50)
Isobutane SCHEMBL20490082 0.82 TSHR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2160397-B1 A NOVEL AND HIGHLY STEREOSELECTIVE PROCESS FOR PREPARING GEMCITABINE AND INTERMEDIATES THEREOF NANJING CAVENDISH BIO ENGINEERING TECHNOLOGY CO LTD (CN) 2014-03-26 EP disclosed
US-20130018181-A1 Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof Nanjing Cavendish Bio-Engineering Technology Co., Ltd. (CN) 2013-01-17 US disclosed
US-8324373-B2 Highly stereoselective process for preparing gemcitabine and intermediates thereof Nanjing Cavendish Bio-Engineering Technology Co., Ltd. (CN) 2012-12-04 US disclosed
US-20100179314-A1 Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof NANJING CAVENDISH BIO-ENGINEERING TECHNOLOGY CO., (CN) 2010-07-15 US disclosed
EP-2160397-A1 A NOVEL AND HIGHLY STEREOSELECTIVE PROCESS FOR PREPARING GEMCITABINE AND INTERMEDIATES THEREOF Nanjing Cavendish Bio-Engineering Technology Co., Ltd. (CN) 2010-03-10 EP disclosed
WO-2008144970-A1 A NOVEL AND HIGHLY STEREOSELECTIVE PROCESS FOR PREPARING GEMCITABINE AND INTERMEDIATES THEREOF Nanjing Cavendish Bio-Engineering Technology Co., Ltd. (CN) 2008-12-04 WO disclosed